Johns Hopkins Psychiatry Guide
Brexpiprazole
INDICATIONS
FDA
FDA
- Adjunctive treatment of major depressive disorder (MDD) in adults
- Treatment of schizophrenia in adults and pediatric patients ages 13 years and older
- Treatment of agitation associated with dementia due to Alzheimer’s disease
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 3, 2025
Citation
Qureshi, Imran. "Brexpiprazole." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787500/all/Brexpiprazole.
Qureshi I. Brexpiprazole. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787500/all/Brexpiprazole. Accessed October 8, 2025.
Qureshi, I. (2025). Brexpiprazole. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787500/all/Brexpiprazole
Qureshi I. Brexpiprazole [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787500/all/Brexpiprazole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Brexpiprazole
ID - 787500
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/10/03/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787500/all/Brexpiprazole
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
